The Reagan-Udall Foundation for the U.S. Food and Drug Administration (FDA) has published a new report outlining efforts to explore a public-private partnership to improve the tracking of antimicrobial use (AMU) in food-producing animals. 

U.S. President Joe Biden recently signed the Fiscal Year (FY) 2023 Omnibus Appropriations Bill, which allocates $25.480 billion in total base discretionary funding for U.S. agencies that are responsible for agriculture and food safety, including the U.S. Food and Drug Administration (FDA).

To strengthen federal food safety regulation, the Reagan-Udall Foundation has published its independent review of the U.S. Food and Drug Administration’s (FDA’s) Human Foods Program, focusing on organizational culture, structure, resources, and authorities. The evaluation will be used to “inform a new vision for the FDA Human Foods Program.”

The Reagan-Udall Foundation opened a Stakeholder Portal on September 16 to collect perspectives and experiences with FDA's human foods program. In addition, the Foundation announced a public meeting of its food-focused Independent Expert Panel.

The Reagan-Udall Foundation has announced five members of its Independent Expert Panel who will evaluate the U.S. Food and Drug Administration’s (FDA’s) human foods program. The evaluation will launch September 8, 2022.

Dr. Robert M. Califf, Commissioner of Food and Drugs at the U.S. Food and Drug Administration (FDA), has contracted the Reagan-Udall Foundation to evaluate the agency’s Human Foods Program.